• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020年新冠疫情期间比利时一家大学医院员工中的新冠病毒血清流行率(COVEMUZ研究)

SARS-COV-2 seroprevalence among employees of a University Hospital in Belgium during the 2020 COVID-19 outbreak (COVEMUZ-study).

作者信息

De Geyter Deborah, Vancutsem Ellen, Van Laere Sven, Piérard Denis, Lacor Patrick, Weets Ilse, Allard Sabine

机构信息

Clinical Biology, Laboratory of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Brussels, Belgium.

Biostatitics and Medical Informatics, Faculty of Medicine and Farmacy, Vrije Universiteit Brussel, Brussels, Belgium.

出版信息

Epidemiol Infect. 2021 Jul 5;149:1-24. doi: 10.1017/S0950268821001540.

DOI:10.1017/S0950268821001540
PMID:34219629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8314061/
Abstract

Between 19 May and 12 June 2020, employees of the UZ Brussel were recruited in this study aiming to document the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence, to investigate the potential work-related risk factors for SARS-CoV-2 infection and to estimate the proportion of asymptomatic infections. In total, 2662 participants were included of whom 7.4% had immunoglobulin G antibodies against SARS-CoV-2. Of the participants reporting a positive polymerase chain reaction for SARS-CoV-2, 89% had antibodies at the time of blood sampling. Eleven per cent of the antibody positive participants reported no recent symptoms suggestive of coronavirus disease 2019 (COVID-19). Participants reporting fever, chest pain and/or anosmia/ageusia were significantly more frequently associated with the presence of antibodies against SARS-CoV-2. The presence of antibodies was highest in the group that had had contact with COVID-19-infected individuals outside the hospital with or without using appropriate personnel protective equipment (PPE) ( < 0.001). Inside the hospital, a statistically significant difference was observed for the employees considered as low-risk exposure compared to the intermediate-risk exposure group ( = 0.005) as well as the high-risk exposure group compared to the intermediate exposure risk group ( < 0.001). These findings highlight the importance of using correct PPE.

摘要

2020年5月19日至6月12日,布鲁塞尔大学医院的员工参与了这项研究,旨在记录严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的血清流行率,调查SARS-CoV-2感染潜在的工作相关风险因素,并估计无症状感染的比例。总共纳入了2662名参与者,其中7.4%的人具有抗SARS-CoV-2的免疫球蛋白G抗体。在报告SARS-CoV-2聚合酶链反应呈阳性的参与者中,89%在采血时已有抗体。11%抗体呈阳性的参与者报告近期无提示2019冠状病毒病(COVID-19)的症状。报告发热、胸痛和/或嗅觉减退/味觉减退的参与者与抗SARS-CoV-2抗体的存在显著更相关。在与医院外COVID-19感染者有接触的组中,无论是否使用适当的个人防护装备(PPE),抗体的存在率最高(<0.001)。在医院内部,与中风险暴露组相比,低风险暴露的员工存在统计学显著差异(=0.005),与中风险暴露组相比,高风险暴露组也存在统计学显著差异(<0.001)。这些发现突出了使用正确PPE的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b6c/8314061/01efc178c0d0/S0950268821001540_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b6c/8314061/73365c5a516e/S0950268821001540_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b6c/8314061/d847044a0b91/S0950268821001540_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b6c/8314061/01efc178c0d0/S0950268821001540_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b6c/8314061/73365c5a516e/S0950268821001540_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b6c/8314061/d847044a0b91/S0950268821001540_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b6c/8314061/01efc178c0d0/S0950268821001540_fig3.jpg

相似文献

1
SARS-COV-2 seroprevalence among employees of a University Hospital in Belgium during the 2020 COVID-19 outbreak (COVEMUZ-study).2020年新冠疫情期间比利时一家大学医院员工中的新冠病毒血清流行率(COVEMUZ研究)
Epidemiol Infect. 2021 Jul 5;149:1-24. doi: 10.1017/S0950268821001540.
2
Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland.瑞士养老院和家庭保健员工中 SARS-CoV-2 抗体的血清流行率、相关因素、经验和态度。
BMC Infect Dis. 2022 Mar 16;22(1):259. doi: 10.1186/s12879-022-07222-8.
3
COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.COVID-19:热点医院?-德国二级保健医院网络中医院员工的 SARS-CoV-2 抗体血清阳性率:一项前瞻性监测研究的中期结果。
Int J Hyg Environ Health. 2021 Jun;235:113771. doi: 10.1016/j.ijheh.2021.113771. Epub 2021 May 20.
4
Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees.德国医院员工中 SARS-CoV-2 抗体的半年纵向血清流行率和规则遵守情况。
Int J Environ Res Public Health. 2021 Oct 19;18(20):10972. doi: 10.3390/ijerph182010972.
5
SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain.西班牙马德里一家军事医院医护人员中 SARS-CoV-2 感染和特异性抗体检测。
Curr Microbiol. 2021 Aug;78(8):2910-2915. doi: 10.1007/s00284-021-02541-6. Epub 2021 Jun 22.
6
Risk factors of SARS-CoV-2 seroprevalence among hospital employees in Italy: a single-centre study.意大利医院员工中 SARS-CoV-2 血清阳性率的风险因素:一项单中心研究。
Intern Med J. 2021 Jul;51(7):1049-1059. doi: 10.1111/imj.15201. Epub 2021 Apr 26.
7
Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.退伍军人事务部医疗保健系统员工中严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染的血清阳性率表明,当在工作环境之外接触 SARS-CoV-2 时,感染的风险更高。
Infect Control Hosp Epidemiol. 2021 Apr;42(4):392-398. doi: 10.1017/ice.2020.1220. Epub 2020 Sep 23.
8
Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff.前瞻性监测研究在一家 1400 床位的大学附属医院进行:家庭内 COVID-19 暴露是医院工作人员 SARS-CoV-2 血清阳性率的主要危险因素。
Transbound Emerg Dis. 2022 Mar;69(2):720-730. doi: 10.1111/tbed.14041. Epub 2021 Mar 9.
9
Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.新冠疫情爆发后,对比利时一家拥有4个院区的公立医院医护人员进行大规模SARS-CoV-2分子和血清学筛查。
J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.07.033. Epub 2020 Jul 31.
10
COVID-19 outbreak among employees of a German hospital: risk factor analysis based on a follow-up questionnaire and seroprevalence.德国一家医院员工中的 COVID-19 疫情:基于随访问卷和血清阳性率的危险因素分析。
Infection. 2024 Oct;52(5):1753-1762. doi: 10.1007/s15010-024-02220-1. Epub 2024 Mar 15.

引用本文的文献

1
Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.肾移植受者和透析患者对 SARS-CoV-2 的体液免疫:SARS-CoV-2 感染和接种疫苗后解析的 IgA 和 IgG 模式。
Virol J. 2024 Jun 13;21(1):138. doi: 10.1186/s12985-024-02410-1.
2
Seroprevalence of SARS-CoV-2 in hospital workers in the southern region of Minas Gerais state in Brazil: An analysis of the pre-vaccine period.巴西米纳斯吉拉斯州南部地区医院工作者中 SARS-CoV-2 的血清流行率:疫苗接种前时期的分析。
Braz J Microbiol. 2023 Jun;54(2):859-871. doi: 10.1007/s42770-023-00966-8. Epub 2023 Apr 13.
3

本文引用的文献

1
Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020.2020 年 3 月至 10 月,比利时全国连续前瞻性横断面研究中针对 SARS-CoV-2 的 IgG 抗体血清阳性率-残留样本。
Euro Surveill. 2022 Mar;27(9). doi: 10.2807/1560-7917.ES.2022.27.9.2100419.
2
Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study.在接种疫苗前,比利时医院医护人员中抗 SARS-CoV-2 抗体的流行率和发生率:一项前瞻性队列研究。
BMJ Open. 2021 Jun 29;11(6):e050824. doi: 10.1136/bmjopen-2021-050824.
3
Determinants of seropositivity for SARS-CoV-2 in hospital staff in the second wave of the pandemic in Slovenia.
斯洛文尼亚第二波大流行期间医院工作人员中 SARS-CoV-2 血清阳性的决定因素。
Int J Occup Med Environ Health. 2022 Oct 3;35(5):571-584. doi: 10.13075/ijomeh.1896.01932. Epub 2022 Jul 15.
Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers.
医护人员中,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗刺突抗体的估计半衰期比抗核衣壳抗体的半衰期长一倍多。
Clin Infect Dis. 2021 Dec 16;73(12):2366-2368. doi: 10.1093/cid/ciab219.
4
T cell response to SARS-CoV-2 infection in humans: A systematic review.人类对 SARS-CoV-2 感染的 T 细胞反应:系统综述。
PLoS One. 2021 Jan 25;16(1):e0245532. doi: 10.1371/journal.pone.0245532. eCollection 2021.
5
Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection.严重急性呼吸综合征冠状病毒2感染的实验室诊断与病毒载量监测
Innovation (Camb). 2020 Nov 25;1(3):100061. doi: 10.1016/j.xinn.2020.100061. Epub 2020 Nov 4.
6
Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.新型冠状病毒肺炎患者恢复期的纵向血清学分析和中和抗体水平。
J Infect Dis. 2021 Feb 13;223(3):389-398. doi: 10.1093/infdis/jiaa659.
7
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.无症状和出现症状前 SARS-CoV-2 感染的发生和传播潜力:一项实时系统评价和荟萃分析。
PLoS Med. 2020 Sep 22;17(9):e1003346. doi: 10.1371/journal.pmed.1003346. eCollection 2020 Sep.
8
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.SARS-CoV-2 血清流行率和医护人员无症状病毒携带情况:一项横断面研究。
Thorax. 2020 Dec;75(12):1089-1094. doi: 10.1136/thoraxjnl-2020-215414. Epub 2020 Sep 11.
9
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
10
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.恒河猴初次接触 SARS-CoV-2 可预防再次感染。
Science. 2020 Aug 14;369(6505):818-823. doi: 10.1126/science.abc5343. Epub 2020 Jul 2.